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Objective: The hypothesis was that Na1/H1 exchange occurring during
normothermic cardioplegia contributes to the development of myocardial
edema during subsequent reperfusion and impairs functional recovery.
Methods: Rat hearts were perfused in a Langendorff apparatus and
submitted to 60 minutes of normothermic cardioplegia and 90 minutes of
reperfusion. Hearts were allocated to one of four groups (n 5 8): inhibition
of Na1/H1 exchanger with HOE642 throughout the whole experiment
(HOE group), only during cardioplegia (HOE-C) or during reperfusion
(HOE-R), and a control group. Results: In HOE and HOE-C groups,
myocardial water content at the end of reperfusion was lower than in the
HOE-R and control groups (526 6 19 and 533 6 18 ml/100 gm dry tissue
vs 632 6 25 and 634 6 17 ml/100 gm dry tissue, respectively, p 5 0.001), left
ventricular end-diastolic pressure increased less after reperfusion (46.6 6
9.7 and 63.2 6 10.0 mm Hg vs 75.1 6 4.3 mm Hg and 85.7 6 8.9 mm Hg,
respectively, p 5 0.006), and recovery of left ventricular developed pressure
was better (46.7% and 45.8% vs 4.5% and 9.8%, p 5 0.048). Relative to the
control group, total lactate dehydrogenase release during reperfusion was
reduced by 80.2%, 69.3% and 36% in HOE, HOE-C, and HOE-R groups,
respectively. Conclusion: Inhibition of the Na1/H1 exchange during normo-
thermic cardioplegia reduces myocardial edema and necrosis during sub-
sequent reperfusion, improving functional recovery. Inhibition of Na1/H1
exchange during reperfusion only has a much smaller effect. (J Thorac
Cardiovasc Surg 1998;115:709-15)
The association of hypothermia and diastolic ar-rest has long been the mainstay of myocardial
protection.1 However, its use has been associated
with modifications in the enzyme function, mem-
brane stability, calcium homeostasis, glucose use,
adenosine triphosphate generation and use, and pH
and water control.2, 3 Normothermic cardiac arrest
may afford adequate protection,4 but no large-scale
controlled studies have assessed the clinical efficacy
and safety of this technique.5 Myocardial edema is a
prominent feature of postcardioplegic reperfusion.6
It reduces ventricular performance and compliance
and limits coronary flow during reperfusion.7 The
mechanism of myocardial edema is not perfectly
understood. During myocardial ischemia, accumu-
lation of diffusible catabolites increases osmotic
pressure on both sides of the sarcolemma.8 Subse-
quent reperfusion results in a rapid washout of
extracellular catabolites, generation of an osmotic
gradient, and water influx to the intracellular space.9
The contribution of Na1/H1 exchange to the
genesis of reperfusion myocardial edema has been
only recently recognized. The Na1/H1 exchanger is
a ubiquitous sarcolemmal transporter that contrib-
utes to regulation of cell volume in many cell types10
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and is stimulated during hypoxia11 in response to
excessive H1 production.12 Recent studies have
demonstrated the important role of Na1/H1 ex-
change occurring during hypoxia in the genesis of
reoxygenation-induced myocardial edema13 and the
ability of HOE642, a highly selective inhibitor of
type 1 Na1/H1 exchanger,14 to prevent it. The
purpose of this study was to test the hypothesis that
Na1 gain related to Na1/H1 exchange taking place
during warm cardioplegic ischemia induces water
uptake and edema formation during subsequent
myocardial reperfusion, impairing functional recov-
ery.
Materials and methods
Experimental model. This study was performed in the
isolated perfused rat heart model. Animals were handled
according to the Recommendations of the Declaration of
Helsinki and the Guiding Principles in the Care and Use
of Animals, and the study was approved by the Research
Commission of the Hospital Universitari Vall d’Hebron.
Sprague-Dawley rats (300 to 400 gm) were deeply anes-
thetized with thiopental sodium (100 mg/kg intraperito-
neally). Hearts were rapidly excised, placed in ice-cold
saline solution, and prepared for positioning on a nonre-
circulating Langendorff apparatus. The aorta was cannu-
lated, and orthograde perfusion of the coronary circula-
tion was quickly started with the oxygenated buffer
solution at a temperature of 37° C.
Experimental protocol. Perfusion protocol consisted of
an equilibration period of 15 minutes, 60 minutes of
cardioplegic arrest, and 90 minutes of reperfusion.
Solutions. During equilibration and reperfusion peri-
ods, a modified Krebs-Henseleit bicarbonate buffer solu-
tion was used. This solution contained 140 mmol/L so-
dium chloride, 24 mmol/L sodium bicarbonate, 2.7
mmol/L potassium chloride, 0.4 mmol/L monobasic potas-
sium phosphate, 1 mmol/L magnesium sulfate, 1.8
mmol/L calcium chloride and 5 mmol/L glucose. It was
prepared daily. The buffer was continuously gassed with
95% oxygen and 5% carbon dioxide at 37° C (pH 7.4). The
cardioplegic solution used was St. Thomas’ Hospital solu-
tion number 2 (Plegisol; Abbott Laboratories, Chicago,
Ill.) to which sodium bicarbonate was added to obtain a
pH of 7.8 according to the manufacturer’s specifications.
Na1/H1 exchange inhibition. Na1/H1 antiport was
blocked with HOE642 (Hoechst AG, Frankfurt Main,
Germany) at a concentration of 7 mmol/L. This concen-
tration has been shown to prevent rigor contracture in
metabolically inhibited isolated myocytes,15 to limit reoxy-
genation edema in the isolated rat heart,13 and to reduce
infarct size in pigs.16 All solutions containing HOE642
were protected from direct light throughout the experi-
ment because of photosensitivity.
Groups of study. Flow rate was adjusted at 10 ml/min
during equilibration. This required a coronary perfusion
pressure of 58 6 4 mm Hg. The cardioplegic solution, St.
Thomas’ Hospital solution number 2, was delivered
through a lateral derivation of the perfusion apparatus at
the rate of 5 ml/min for 2 minutes at 37° C. Arrested
hearts were immersed in the same cardioplegic solution,
with temperature maintained between 34° and 37° C.
Reperfusion was produced by restoring flow at 10 ml/min.
Hearts were allocated to one of four groups (n 5 8 in each
group; Fig. 1). In one group, 7 mmol/L HOE642 was
added to the equilibration, cardioplegic, and reperfusion
solutions (HOE group). To investigate whether Na1/H1
antiport inhibition was effective during cardioplegia or
during reperfusion, HOE642 was added to only the car-
dioplegic solution in a second group (HOE-C group) and
to only the reperfusion solution in a third group (HOE-R
group). Finally, HOE642 was not added to any of the
solutions in a control group.
The effect of cardioplegia without reperfusion on myo-
cardial water content was analyzed in an additional series
of experiments. In these series, hearts were perfused as
the HOE or the control group (n 5 4) and removed from
the Langendorff system 1 hour after cardioplegic arrest
without reperfusion.
Measurements
Functional data. Left ventricular pressure was moni-
tored by introducing a fluid-filled latex balloon in the
cardiac cavity through the left atrium, placed at the tip of
a Cordis 5F catheter (Cordis Corporation, Miami, Fla.)
connected to a Baxter 43600F pressure transducer (Baxter
S.A., Valencia, Spain). The balloon was inflated with
saline solution to keep left ventricular end-diastolic pres-
sure (LVEDP) between 10 and 12 mm Hg during the
Fig. 1. Experimental protocol. Hearts were subjected to
15 minutes of equilibration perfusion (EQUIL) with mod-
ified Krebs-Henseleit solution, 60 minutes of St. Thomas’
Hospital cardioplegic solution number 2 (CARDIOPLE-
GIA), and 90 minutes of reperfusion with modified Krebs-
Henseleit solution (REPERFUSION). In the HOE group,
HOE642 at the dose of 7 mmol/L was added both to the
modified Krebs-Henseleit solution and to St. Thomas’
Hospital cardioplegic solution number 2. In the HOE-C
group, HOE642 was added only to the cardioplegic solu-
tion. In the HOE-R group, HOE642 was added only to
the reperfusion solution. Temperature of all solutions was
kept between 34° and 37° C.
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equilibration period. The signal was digitized and contin-
uously recorded on hard disk with the aid of ad hoc–
developed software. Heart rate, left ventricular systolic
pressure, and LVEDP were continuously monitored. Left
ventricular developed pressure (LVDP) was calculated as
the peak systolic pressure minus the LVEDP and ex-
pressed as the percent of the basal value at the end of the
equilibration period.
Lactate dehydrogenase (LDH) release. Heart injury dur-
ing reperfusion was assessed by analysis of LDH release.
LDH activity was assayed by spectrophotometric analysis
(SLT Spectra Vision, Gro¨dig, Austria) in 0.05 mol/L
phosphate buffer (monobasic potassium phosphate;diba-
sic potassium phosphate, 1 mmol/L sodium pyruvate, and
0.3 mmol/L reduced nicotinamide adenine dinucleotide.
Results were expressed as units of activity (IU) released
per gram dry weight. LDH activity was measured in
samples taken from the coronary effluent at 1, 2, 3, 4, 6, 8,
and 10 minutes and then every 10 minutes until 90
minutes of reperfusion.
Myocardial water content. At the end of the reperfusion
period, hearts were removed from the Langendorff appa-
ratus and total myocardial water content was analyzed as
previously described elsewhere.17 Tissue samples corre-
sponding to about one third of the heart were obtained
immediately after removal of the hearts and were rapidly
introduced into assay tubes that had been weighed 1 hour
before on a high-precision scale (Mettler AJ50; Mettler
Instruments, Greifensee, Switzerland). The tubes with the
samples were weighed immediately before and after 24
hours of desiccation at 100° C (Selecta 200; J. P. Selecta,
S.A., Abrera, Spain). Myocardial water content was cal-
culated as the difference between wet and dry weights and
expressed as milliliters per 100 grams dry weight.
Statistical analysis. Commercially available software
was used for statistical analysis (SPSS/PC1 V4.0; SPSS,
Inc., Chicago, Ill.). Statistical comparisons between
groups were performed by analysis of variance after
having assessed the data for normal distribution. Individ-
ual comparisons were performed by means of the less
significant difference test. The relationship between myo-
cardial water content and function recovery was investi-
gated by means of linear regression analysis. A critical p
value of 0.05 was used for all tests. All values are
expressed as mean 6 standard error of the mean.
Results
Functional data. Results of left ventricular func-
tion measurements in the four study groups are
summarized in Table I. There were no differences
between groups at baseline. The maximal elevations
of LVEDP during cardioplegic arrest were similar
among all groups analyzed and were reached at
similar times (34.1 6 1.5, 26.7 6 1.5, 31.1 6 1.1, and
31.2 6 1.5 minutes in the HOE, HOE-C, HOE-R,
and control groups, respectively; p not significant).
During reperfusion, HOE and HOE-C groups
showed a similar functional outcome, significantly
better than that observed in HOE-R and control
groups. The effects of HOE642 on the changes in
LVEDP and LVDP throughout the experiment are
shown in detail in Fig. 2. The presence of HOE642
in the cardioplegic solution did not modify LVEDP
during normothermic cardioplegic arrest, but it did
prevent the increase in LVEDP and improve recov-
ery of LVDP during the first 30 minutes of reperfu-
sion. After 50 minutes of reperfusion, there was a
loss of contractile activity in both groups (from 60 to
90 minutes, p not significant).
LDH-release. No study group showed a peak of
enzyme release on reperfusion. A small, sustained
LDH release was observed throughout the reper-
fusion period in the control group. In the HOE
and HOE-C groups, only minimal LDH release
was observed during reperfusion, whereas the
HOE-R group showed an intermediate result
(Fig. 3).






30 min 60 min 90 min
LVEDP (mm Hg)
HOE group 10.6 6 1.2 43.7 6 6.3 46.6 6 9.7*† 51.0 6 11.4 55.8 6 10.8
HOE-C group 11.0 6 2.1 52.7 6 7.6 63.2 6 10.0 53.3 6 8.1* 56.6 6 9.2
HOE-R group 10.8 6 2.3 56.0 6 6.4 75.1 6 4.3 68.6 6 6.4 62.0 6 11.6
Control group 10.2 6 1.5 45.4 6 7.1 85.7 6 8.9 71.7 6 8.5 66.8 6 7.2
LVDP (mm Hg)
HOE group 69.4 6 8.4 — 32.4 6 9.2*† 20.3 6 2.1 17.9 6 3.3*†
HOE-C group 75.2 6 6.4 — 34.4 6 1.5*† 35.8 6 9.3*† 27.5 6 1.4
HOE-R group 67.5 6 5.1 — 6.6 6 2.3 6.4 6 2.1 2.8 6 1.6
Control group 71.7 6 5.6 — 3.1 6 6.3 15.3 6 8.7 11.1 6 4.3
All values expressed as mean 6 standard error.
*p , 0.05 vs control group.
†p , 0.05 vs HOE-R group.
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Myocardial edema. Myocardial water content in
the different study groups is shown in Fig. 4. In the
two series of nonreperfused hearts, water content
was significantly lower than in reperfused hearts
(399 6 8 ml/100 gm dry tissue in nonreperfused
hearts vs 581 6 24 ml/100 gm dry tissue in reper-
fused hearts, p 5 0.001). Reperfusion resulted in
lower myocardial water contents in the HOE and
HOE-C groups (526 6 20 and 533 6 18 ml/100 gm
dry tissue, respectively) than in the HOE-R and
control groups (632 6 25 and 634 6 17 ml/100 gm
dry tissue, respectively; p 5 0.006).
Functional data versus water content. Linear re-
gression analysis demonstrated a close relationship
between myocardial water content and functional
parameters during the reperfusion period. After 30
minutes of reperfusion, LVEDP was directly corre-
lated (r 5 0.9364, p 5 0.001) and LVDP was
inversely correlated (r 5 –0.815, p 5 0.001) with
myocardial water content (Fig. 5).
Discussion
This study analyzed the effect of inhibition of
Na1/H1 exchange on the effectiveness of myocar-
dial protection afforded by normothermic cardiople-
gia in the isolated, crystalloid-perfused rat heart.
Addition of HOE642 to the cardioplegic solution
resulted in less myocardial edema, less enzyme
release, and improved functional recovery during
subsequent reperfusion. Addition of HOE642 to the
reperfusion medium did not significantly enhance
this protective effect. These results indicate that
harmful Na1/H1 exchange takes place during nor-
mothermic cardioplegia and that its pharmacologic
inhibition may result in improved myocardial pro-
tection.
Previous studies. It has been shown that Na1/H1
exchange inhibition during ischemia or anoxia re-
duces myocardial necrosis during subsequent reper-
fusion or reoxygenation.12, 13, 16 The effects of inhi-
bition of Na1/H1 exchange during cardioplegia
have been less well investigated, and the effect of
Na1/H1 exchange on postcardioplegic myocardial
edema has not yet been described. Because the
activity of Na1/H1 sarcolemmal exchanger is mark-
edly depressed by hypothermia,18 the addition of
Na1/H1 exchange inhibition during hypothermic
cardioplegia should be of little use. However, im-
proved myocardial preservation has been recently
described when 1 mmol/L HOE642 was added dur-
ing hypothermic cardiac arrest to St. Thomas’ Hos-
pital cardioplegic solution number 2 for 12 hours at
Fig. 2. Functional results during cardioplegic and reper-
fusion period in control and HOE groups. LVEDP was
measured as percentage increase, related to a 10 to 12 mm
Hg fixed value in the equilibration period. LVDP
(LVdevP) was measured as percentage recovery, related
to the baseline LVDP of the equilibration period. Each
point is expressed as mean 6 standard error of the mean.
Asterisk indicates p , 0.05 between groups.
Fig. 3. Total LDH release throughout 90 minutes of
reperfusion in HOE, HOE-C, HOE-R, and control
groups. Error bars correspond to standard error of the
mean. Asterisk represents p 5 0.032 vs control group;
double asterisk represents p , 0.01 vs control group and
HOE-R group.
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4° C19 or when HOE694 was added for 5 hours at
7.5° C and for 2 hours at 28° C.20
Normothermic cardioplegia was selected in this
study because several recent studies have described
the potential advantages of this type of protection
compared with hypothermia,2, 3, 5 and because hypo-
thermia cannot be performed in patients with cryo-
agglutinins.4 St. Thomas’ Hospital solution is widely
used21 because of its convenience and low price.
This solution contains bicarbonate in its composi-
tion. Previous studies indicate that HCO3
–/Na1
symport represents a complementary route of Na1
entry to cardiac cells during energy deprivation, and
that removal of bicarbonate from the extracellular
media and addition of HOE642 have additive ben-
eficial effects against hypercontracture and swelling
induced by subsequent reoxygenation.13 The bene-
ficial effects of HOE642 on edema and function of
reperfused myocardium could be even more impor-
tant when added to bicarbonate-free cardioplegic
solutions.
Important myocardial edema has been shown to
occur during reperfusion after regional normother-
mic ischemia9 and hypothermic cardioplegia.7, 22
This edema was explained as a consequence of the
osmotic gradient generated by the abrupt normal-
ization of extracellular osmotic pressure, and it
could be limited by hyperosmotic reperfusion.8, 17 It
has also been shown recently that myocardial reoxy-
genation after hypoxia may induce severe myocar-
dial edema and that Na1/H1 exchange plays an
important role in its genesis.13 Myocardial edema
may have detrimental effects on contractile and
microvascular function of reperfused myocardi-
um,7, 18 and swelling may contribute along with
hypercontracture and cytoskeletal fragility to sar-
colemmal rupture and cell death on restoration of
oxygen supply.15 This study describes myocardial
edema assessed from measurement of total water
content after normothermic cardioplegia. The fact
that Na1/H1 exchange inhibition alters this param-
eter demonstrates that Na1/H1 exchange is in-
volved in edema formation, but whether the edema
is the direct result of Na1 transport remains to be
determined.
In this study, a narrow correlation was found
between myocardial water content and functional
parameters after 30 minutes of reperfusion, a mo-
ment when myocardial edema has already reached
values virtually identical to those observed at the
end of the 90-minute normoxic perfusion period.13
This narrow correlation is consistent with the work-
ing hypothesis of this study and with previous obser-
vations suggesting that myocardial edema has a
Fig. 4. Water content is expressed as difference between wet and dry heart weights, measured after 24
hours of desiccation at 100° C. Measurements were performed without reperfusion (Cardioplegia) or after
90 minutes of reperfusion (Cardioplegia 1 Reperfusion). Each group is represented as mean value 6
standard error of the mean. Asterisk represents p 5 0.001 vs control group in the cardioplegia plus
reperfusion study.
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detrimental influence on contractile function, al-
though a causal relationship has not yet been estab-
lished.23 It has been shown that osmotic stress may
reduce Ca21 sensitivity in rat myocardium,24 that
swelling may increase spatial separation between
contractile filaments,25 and that moderate hyperto-
nicity of the perfusion buffer improves contractility
in the working rat heart.26 On the other hand, other
studies suggest that myocardial function may influ-
ence myocardial water content. In the isolated heart,
diminished contractility may result in myocardial
edema,27 and changes in intracellular volume may
modulate Na1/H1 exchange and influence intracel-
lular pH.28 Finally, although enzyme release was
small in all groups, it cannot be ruled out that a
beneficial effect of Na1/H1 inhibition on Ca21
overload during reperfusion could have resulted in
less cell death and better functional recovery.
Critique of the methods. Crystalloid perfusion of
the isolated heart is associated to myocardial ede-
ma.13, 23 Under normoxic conditions, myocardial
water content increases during the first 30 min of
crystalloid perfusion and stabilizes thereafter.13 This
perfusion-associated edema is due to the lack of
oncotic strength of the crystalloid perfusate, but
changes in myocardial water content induced by
subsequent anoxia and reoxygenation are largely
independent of the oncotic pressure of the buffer.13
The model used thus seems valid to analyze the
changes in reperfusion edema in response to treat-
ments, although the magnitude of these changes
must be measured in relation to a higher value of
myocardial water content.
Although desiccation is the method most widely
used to measure myocardial water content, it is not
an ideal method. First, its results may be influenced
by the time between the end of reperfusion and
weighing, and by the number and strength of beats
occurring during this period. The fact that this
period was minimal and similar in all the study
groups, however, makes it extremely unlikely that
the observed intergroup differences in myocardial
water content are artifactual. Second, it does not
allow discrimination between intracellular and ex-
tracellular edema.
In this study, a small but sustained enzyme release
was observed throughout the reperfusion period in
all treatment groups, and functional recovery during
reperfusion was incomplete. The normothermic car-
dioplegia protocol used thus affords incomplete
myocardial protection against 60 minutes of isch-
emia. This could be due in part to the large increase
in LVEDP favored by the isovolumic conditions,
probably greater than those observed during cardiac
surgery in human patients. Moreover, the loss of
myocardial function observed at the end of the
reperfusion period probably reflects progressive de-
terioration of the preparation associated with crys-
talloid perfusion. However, the model used allowed
the detection of a greater and faster initial recovery
of left ventricular function when HOE642 was
added to the cardioplegic solution.
Implications. This study was conducted in an
asanguineous, nonworking crystalloid-perfused rat
heart, and its conclusions therefore cannot be di-
rectly extrapolated to the clinical situation. The
advantages of blood compared with pure crystalloid
perfusion are well known.29 Blood vehicle for car-
Fig. 5. Regression analysis of functional results versus
myocardial water accumulation. Regression lines were
calculated for values obtained from control and HOE
groups. Each symbol represents one heart. LVEDP in-
crease after 30 minutes of reperfusion is expressed as a
percentage of basal LVEDP at the end of the equilibra-
tion period. LVDP (LVDevP) recovery after 30 minutes of
reperfusion is expressed as a percentage of LVDP mea-
sured at the end of the equilibration period.
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dioplegic delivery blends normal oncotic strength
and viscosity with buffering capacity, hormonal ef-
fects, antioxidant properties, and other advantages
associated with the presence of blood factors.30 The
presence of oxygen in blood cardioplegic prepara-
tions helps to satisfy oxygen demand, already re-
duced by loss of the electromechanical activity.
R E F E R E N C E S
1. Mauney MC, Kron IL. The physiologic basis of warm cardio-
plegia. Ann Thorac Surg 1995;60:819-23.
2. Vaughn CC, Opie JC, Florendo FT, Lowell PA, Austin J.
Warm blood cardioplegia. Ann Thorac Surg 1993;55:1227-32.
3. Lichtenstein SV, Ashe KA, El Dalati H, Cusimano RJ, Panos
A, Slutsky AS. Warm heart surgery. J Thorac Cardiovasc
Surg 1991;101:269-74.
4. Christakis GT, Koch JP, Deemar KA, Fremes SE, Sinclair L,
Chen E, et al. A randomized study of the systemic effects of
warm heart surgery. Ann Thorac Surg 1992;54:449-59.
5. Naylor CD, Lichtenstein SV, Fremes SE, Warm Heart
Investigators. Randomized trial of normothermic versus hy-
pothermic coronary bypass surgery. Lancet 1994;343:559-63.
6. Menasche´ P, Dunica S, Kural S, Touchot B, Chollet A, Steg
G, et al. An asanguineous reperfusion solution: an effective
adjunct to cardioplegic protection in high-risk valve opera-
tions. J Thorac Cardiovasc Surg 1984;88:278-86.
7. Foglia RP, Steed DL, Follette DM, DeLand E, Buckberg
GD. Iatrogenic myocardial edema with potassium cardiople-
gia. J Thorac Cardiovasc Surg 1979;78:217-22.
8. Tranum-Jensen J, Janse MJ, Fiolet JWT, Krieger JC,
D’Alnoncourt CN, Durrer D. Tissue osmolality, cell swelling,
and reperfusion in acute regional myocardial ischemia in the
isolated porcine heart. Circ Res 1981;49:364-81.
9. Jennings RB, Schaper J, Hill ML, Steenbergen C, Reimer
KA. Effects of reperfusion late in the phase of reversible
ischemic injury: changes in cell volume, electrolytes, metab-
olites, and ultrastructure. Circ Res 1985;56:262-78.
10. Demaureux N, Grinstein S. Na1/H1 antiport: modulation by
ATP and role in cell volume regulation. J Exp Biol 1994;196:
389-404.
11. Anderson SE, Murphy E, Steenbergen C, London RE, Cala
PM. Na1/H1 exchange in myocardium: effects of hypoxia and
acidification on Na1 and Ca21. Am J Physiol 1990;259:
C940-8.
12. Piper HM, Balser C, Ladilov YV, Scha¨fer M, Siegmund B,
Ruiz-Meana M, et al. The role of Na1/H1 exchange in
ischemia-reperfusion. Basic Res Cardiol 1996;91:191-202.
13. Inserte J, Garcia-Dorado D, Ruiz-Meana M, Solares J,
Soler-Soler J. Role of Na1/H1 exchange occurring during
hypoxia in the genesis of reoxygenation-induced myocardial
edema. J Mol Cell Cardiol 1997;29:1167-75.
14. Scholz W, Albus U, Counillon L, Go¨gelein H, Lang H-J, Linz
W, et al. Protective effects of HOE642, a selective sodium-
hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia
and reperfusion. Cardiovasc Res 1995;29:260-8.
15. Ruiz-Meana M, Garcia-Dorado D, Gonza´lez MA, Barrabe´s
JA, Soler-Soler J. Effect of osmotic stress on sarcolemmal
integrity of isolated cardiomyocytes following transient met-
abolic inhibition. Cardiovasc Res 1995;30:64-9.
16. Garcia-Dorado D, Gonza´lez MA, Barrabe´s JA, Ruiz-Meana
M, Solares J, Lidon R, et al. Prevention of ischemic rigor
contracture during coronary occlusion by inhibition of
Na1/H1 exchange. Cardiovasc Res 1997;35:80-9.
17. Garcia-Dorado D, The´roux P, Mun˜oz R, Alonso J, Elizaga J,
Fernandez-Avile´s J, et al. Favorable effects of hyperosmotic
reperfusion on myocardial edema and infarct size. Am J
Physiol 1992;262:H17-22.
18. Drewnoska K, Clemo HF, Baumgarten CM. Prevention of
myocardial intracellular edema induced by St. Thomas’ Hos-
pital cardioplegic solution. J Mol Cell Cardiol 1991;23:1215-
21.
19. Myers ML, Karmazyn M. Improved cardiac function after
prolonged hypothermic ischemia with the Na1/H1 exchange
inhibitor HOE694. Ann Thorac Surg 1996;61:1400-6.
20. Shipolini AR, Avkiran M, Edmondson SJ, Hearse DJ, Gali-
n˜anes M. Addition of Na/H inhibitor to cardioplegia en-
hances myocardial preservation in a temperature-indepen-
dent manner [abstract]. Circulation 1996(suppl 1);94:I536.
21. Hendry PJ, Masters RG, Haspect A. Is there a place for cold
crystalloid cardioplegia in the 1990s? Ann Thorac Surg
1994;58:1690-4.
22. Kay HR, Levine FH, Fallon JT, Grotte GJ, Butchart EG,
Rao S, et al. Effect of cross-clamp time, temperature, and
cardioplegic agents on myocardial function after induced
arrest. J Thorac Cardiovasc Surg 1978;76:590-603.
23. Rubboli A, Sobotka PA, Euler DE. Effect of acute edema on
left ventricular function and coronary vascular resistance in
the isolated rat heart. Am J Physiol 1994;267:H1054-61.
24. Godt RE, Maughan DW. Influence of osmotic compression
on calcium activation and tension in skinned muscle fibers of
the rabbit. Pflugers Arch 1981;391:334-7.
25. Zhao M, Sonnenblick EH, Zhang H, Eng C. Increase in
myofilament separation in the “stunned” myocardium. J Mol
Cell Cardiol 1992;24:269-76.
26. Ben-Haim SA, Hayam G, Edoute Y, Better OS. Effect of
hypertonicity on contractility of isolated working rat left
ventricle. Cardiovasc Res 1992;26:379-82.
27. Anderson SE, Johnson JA. Tissue-fluid pressure measured in
perfused rabbit hearts during osmotic transients. Am J
Physiol 1987;252:H1227-37.
28. Whalley DW, Hemsworth PD, Rasmussen HH. Sodium-
hydrogen exchange in guinea-pig ventricular muscle during
exposure to hyperosmolar solutions. J Physiol 1991;444:193-
212.
29. Walters HL 3rd, Digerness SB, Naftel DC, Waggoner JR 3rd,
Blackstone EH, Kirklin JW. The response to ischemia in
blood perfused vs crystalloid perfused isolated rat heart
preparations. J Mol Cell Cardiol 1992;24:1063-77.
30. Ohashi T, Yamamoto F, Yamamoto H, Ichikawa H, Shibata
T, Kawashima Y. Transient reperfusion with acidic solution
affects postischemic functional recovery: studies in the iso-
lated working rat heart. J Thorac Cardiovasc Surg 1996;111:
613-20.
The Journal of Thoracic and
Cardiovascular Surgery
Volume 115, Number 3
Tritto et al. 7 1 5
